Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Condition:   Type 2 Diabetes Mellitus With Complication Interventions:   Drug: Canagliflozin;   Drug: Pioglitazone Sponsor:   First Affiliated Hospital Xi'an Jiaotong University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials